The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2026

Filed:

Sep. 25, 2019
Applicant:

Alto Neuroscience, Inc., Mountain View, CA (US);

Inventors:

Thomas N. Chase, Washington, DC (US);

Kathleen E. Clarence-Smith, Washington, DC (US);

Assignee:

ALTO NEUROSCIENCE, INC., Mountain View, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/428 (2006.01); A61K 31/138 (2006.01); A61K 31/4178 (2006.01); A61K 31/423 (2006.01); A61K 31/438 (2006.01); A61K 31/439 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 31/5377 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/428 (2013.01); A61K 31/138 (2013.01); A61K 31/4178 (2013.01); A61K 31/423 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/5377 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01);
Abstract

The present invention provides a combination of a 5HT3-antagonist and/or a NK-1 antagonist with 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine and with fluoxetine or a pharmaceutically acceptable salt or solvate thereof, zonisamide or a pharmaceutically acceptable salt or solvate thereof, or a statin or a pharmaceutically acceptable salt or solvate thereof, for use for treating a protein misfolding neurodegenerative disease such as Alzheimer's disease, Lewy body disease, Parkinson's disease, or Huntington's disease.


Find Patent Forward Citations

Chase, Thomas. (2026). Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases (U.S. Patent No. 12622895). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12622895

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…